Stay updated with breaking news from Pharma Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agios Pharmaceuticals sells its 15% royalty rights on U.S. net sales of Servier's vorasidenib to Royalty Pharma for $905 million upon FDA approval.
The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering...
Redx Pharma Plc (LON:REDX – Get Free Report) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 13.67 ($0.17) and traded as high as GBX 33 ($0.42). Redx Pharma shares last traded at GBX 15 ($0.19), with a volume of 1,420,135 […]
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in ...
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug ...